Take Limited adopts FY26 financials at 25th AGM, reappoints auditors
- Take Limited adopted standalone and consolidated financial statements for FY26
- Mr. Parmeshvar Dhangare re-appointed as Director following retirement by rotation
- M/s. A. Raghavendra Rao & Associates appointed as Statutory Auditors for five years
- Company outlined AI-led healthcare strategy including Take.Health and One Minute Clinic
*this image is generated using AI for illustrative purposes only.
Take Limited held its 25th Annual General Meeting on September 29, 2026, adopting the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. The meeting also approved the re-appointment of Mr. Parmeshvar Dhangare as a director and the appointment of new statutory and secretarial auditors.
The AGM was conducted through Video Conferencing and Other Audio-Visual Means in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Sunil Patra, Managing Director and Chief Financial Officer, served as the Chairman of the meeting.
Strategic updates on AI-led healthcare
During his address, Mr. Patra highlighted that FY26 marked an important phase of operational and strategic transition for the company. He detailed the company's AI-led healthcare vision, which includes three complementary components supported by a common AI and data foundation:
- Take.Health: Focuses on deepening consumer engagement and monetisation.
- Unified AI Platform: Aims to expand the provider base.
- One Minute Clinic initiative: Involves a measured rollout of this model.
The Chairman also outlined plans to develop diversified consumer revenue streams through longevity and wellness initiatives. He emphasised the importance of disciplined execution, phased capital deployment, regulatory clearances, and market adoption, noting that certain initiatives remain at an early stage.
Key resolutions passed
Members approved five ordinary resolutions during the meeting. The voting results from remote e-voting and e-voting conducted at the AGM will be submitted to stock exchanges and placed on the company website within prescribed timelines.
| Sr. No. | Particulars | Type of Resolution |
|---|---|---|
| 1 | Adoption of audited standalone financial statements for FY26 | Ordinary |
| 2 | Adoption of audited consolidated financial statements for FY26 | Ordinary |
| 3 | Re-appointment of Mr. Parmeshvar Dhangare as Director | Ordinary |
| 4 | Appointment of M/s. A. Raghavendra Rao & Associates as Statutory Auditors for five years | Ordinary |
| 5 | Appointment of M/s. Hemang Satra & Associates as Secretarial Auditors for five years | Ordinary |
Governance and attendance
The meeting was attended by the Board of Directors, including Independent Directors Ms. Pushpa Joshi, Mr. Kanwar Nitin Singh, and Mr. Peeyush Sethia. Non-Executive Directors Mr. Parmeshvar Dhangare and Mr. Vilas Munis were also present. Ms. Vandana Gupta served as the Company Secretary and Compliance Officer.
M/s. Aarju Agrawal & Associates acted as the Scrutinizer for the AGM. The statutory auditors, M/s. A. Raghavendra Rao & Associates, were present in attendance. The meeting concluded at 12:30 pm.
Historical Stock Returns for TAKE
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.96% | -20.24% | -21.62% | -68.07% | +10.10% | -75.02% |
How will the phased capital deployment for the 'One Minute Clinic' initiative impact Take Limited's short-term cash flow and profitability metrics?
What specific regulatory hurdles remain for the Unified AI Platform to achieve broader provider adoption in the Indian healthcare market?
How does the new statutory auditor appointment influence investor confidence regarding the transparency of the company's AI-driven revenue recognition?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
